GreenGene Recombinant Factor VIII

recombinant factor VIII · Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GreenGene Recombinant Factor VIII, covering 2012-04-02 to 2012-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A [Phase 3]